Myasthenia Gravis Treatment Market Gains Strength with Orphan Drug...

เพิ่มบล็อก อื่นๆ

2025-08-26 08:16:17 -

Myasthenia Gravis Treatment Market Gains Strength with Orphan Drug Designations

The global myasthenia gravis treatment market size was valued at USD 2.01 billion in 2022 and is projected to reach USD 4.26 billion by 2030, expanding at a CAGR of 9.0% between 2023 and 2030. Market growth is primarily driven by the rising adoption of immunotherapies, regulatory approvals for promising drugs, the emergence of biologics, and the increasing awareness of rare diseases....

0 ความคิดเห็น 0 หุ้น 6 มุมมอง 0 บทวิจารณ์